{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:52:24Z","timestamp":1754261544934,"version":"3.40.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajog.2022.12.303","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:01:32Z","timestamp":1671606092000},"page":"474-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of preterm delivery and small for gestational age among women with inflammatory bowel disease using tumor necrosis factor alpha inhibitors during pregnancy"],"prefix":"10.1016","volume":"228","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie J.","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-5961","authenticated-orcid":false,"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.12.303_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/pds.4695","article-title":"Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants","volume":"28","author":"Eworuke","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2022.12.303_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jri.2007.11.003","article-title":"Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model","volume":"78","author":"Holmgren","year":"2008","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2022.12.303_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1095\/biolreprod50.5.1108","article-title":"Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha","volume":"50","author":"Silver","year":"1994","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2022.12.303_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trsl.2011.12.002","article-title":"Inflammatory bowel disease and pregnancy: overlapping pathways","volume":"160","author":"Nasef","year":"2012","journal-title":"Transl Res"},{"key":"10.1016\/j.ajog.2022.12.303_bib5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2022.12.303_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajog.2022.12.303_bib7","first-page":"680","article-title":"Five-year safety data from ENCORE, a European observational safety registry for adults with Crohn\u2019s disease treated with infliximab [Remicade\u00ae] or conventional therapy","volume":"11","author":"D\u2019Haens","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ajog.2022.12.303_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/CLEP.S269400","article-title":"Impact of the transition from ICD-9-CM to ICD-10-CM on the identification of pregnancy episodes in US health insurance claims data","volume":"12","author":"Sarayani","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ajog.2022.12.303_bib9","article-title":"Validation of algorithms to estimate gestational age in Medicaid analytic eXtract data","author":"Yanmin Zhu","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2022.12.303_bib10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pds.4843","article-title":"Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database","volume":"28","author":"Knox","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2022.12.303_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.3743","article-title":"Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results","volume":"24","author":"Margulis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2022.12.303_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/pds.3740","article-title":"Accuracy of ICD-9-CM coding to identify small for gestational age newborns","volume":"24","author":"Phiri","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822025819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822025819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:35:57Z","timestamp":1715232957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822025819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0002937822025819"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.12.303","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of preterm delivery and small for gestational age among women with inflammatory bowel disease using tumor necrosis factor alpha inhibitors during pregnancy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.12.303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}